Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: Double-blind, Double-dummy, Randomised, Placebo-controlled, Multi-centre Phase III Study on the Efficacy and Tolerability of a 8-week Treatment With Budesonide vs. Mesalazine vs. Placebo in Patients W
Brief Summary: The purpose of this study is to determine whether budesonide or mesalazine is more active in the treatment of lymphocytic colitis.